A minority-group of renal cell cancer patients with high infiltration of CD20+B-cells is associated with poor prognosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A minority-group of renal cell cancer patients with high infiltration of CD20+B-cells is associated with poor prognosis

Published:2018-10 Issue:7 Volume:119 Page:840-846
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Sjöberg Elin,Frödin Magnus,Lövrot John,Mezheyeuski Artur,Johansson Martin,Harmenberg Ulrika,Egevad Lars,Sandström Per,Östman Arne

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s41416-018-0266-8.pdf

Reference32 articles.

1. Hsieh, J. J. et al. Renal cell carcinoma. Nat. Rev. Dis. Primers 3, 17009 (2017).

2. Ghatalia, P., Zibelman, M., Geynisman, D. M. & Plimack, E. R. Checkpoint inhibitors for the treatment of renal cell carcinoma. Curr. Treat. Options Oncol. 18, 7 (2017).

3. Harlander, S. et al. Combined mutation in Vhl, Trp53 and Rb1 causes clear cell renal cell carcinoma in mice. Nat. Med. 23, 869–877 (2017).

4. Choueiri, T. K. & Motzer, R. J. Systemic therapy for metastatic renal-cell carcinoma. N. Eng. J. Med. 376, 354–366 (2017).

5. Choueiri, T. K. et al. Cabozantinib versus everolimus in advanced renal-cell carcinoma. N. Eng. J. Med. 373, 1814–1823 (2015).

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fc receptor‐like A promotes malignant behavior in renal cell carcinoma and correlates with tumor immune infiltration;Cancer Medicine;2024-08

2. The roles of tertiary lymphoid structures in genitourinary cancers: a comprehensive review of current advances and clinical applications;International Journal of Surgery;2024-07-08

3. Tumor infiltrating B lymphocytes (TIBs) associate with poor clinical outcomes, unfavorable therapeutic benefit and immunosuppressive context in metastatic clear cell renal cell carcinoma (mccRCC) patients treated with anti-PD-1 antibody plus Axitinib;Journal of Cancer Research and Clinical Oncology;2024-05-19

4. Molecular mechanisms and clinical relevance of endothelial cell cross-talk in clear cell renal cell carcinoma;Upsala Journal of Medical Sciences;2024-05-08

5. Integrated Bioinformatics and Experimental Validation to Identify a Disulfidptosis-Related lncRNA Model for Prognostic Prediction in Papillary Renal Cell Carcinoma;Combinatorial Chemistry & High Throughput Screening;2024-04-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3